A New Model of Care for Familial Hypercholesterolaemia from Western Australia: Closing a Major Gap in Preventive Cardiology

• Published in: Heart, lung & circulation Vol. 19; no. 7; pp. 419 - 422
• Main Authors: Watts, Gerald F., MD, FRACP, van Bockxmeer, Frank M., PhD, Bates, Timothy, FRACP, Burnett, John R., MD, FRCPA, Juniper, Amanda, BHSc, O’Leary, Peter, PhD
• Format: Journal Article
• Language: English
• Published: Australia Elsevier B.V 01.07.2010
• Subjects: Adolescent; Adult; Algorithms; Cardiovascular; Cardiovascular Diseases - prevention & control; Cascade screening; Child; Critical Pathways; Familial hypercholesterolaemia; Female; Genetic testing; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Hyperlipoproteinemia Type II - diagnosis; Hyperlipoproteinemia Type II - drug therapy; Male; Middle Aged; Model of care; Patient Care Team; Patient Selection; Preventive cardiology; Preventive Health Services; Results; Risk Reduction Behavior; Treatment; Western Australia; Young Adult; Western Australia; Treatment; Model of care; Results; Familial hypercholesterolaemia; Preventive cardiology; Genetic testing; Cascade screening

Familial hypercholesterolaemia (FH) is the most common monogenic cause of premature coronary artery disease. FH remains underdiagnosed and inadequately treated, with no national strategies for dealing with the problem. We report an executive summary of a comprehensive model of care for FH developed...